Routine Use of the Pneumonia Severity Index for Guiding the Site-of-Treatment Decision of Patients with Pneumonia in the Emergency Department: A Multicenter, Prospective, Observational, Controlled Cohort Study
Background. Although the Pneumonia Severity Index (PSI) has been extensively validated, little is known of the impact of its routine use as an aid to site-of-treatment decisions for patients with pneumonia who present to emergency departments (EDs). Methods. A prospective, observational, controlled...
Gespeichert in:
| Veröffentlicht in: | Clinical infectious diseases 2007-01, Vol.44 (1), p.41-49 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 49 |
|---|---|
| container_issue | 1 |
| container_start_page | 41 |
| container_title | Clinical infectious diseases |
| container_volume | 44 |
| creator | Renaud, Bertrand Coma, Eva Labarere, Jose Hayon, Jan Roy, Pierre-Marie Boureaux, Hélène Moritz, Fabienne Cibien, Jean François Guérin, Thomas Carré, Emmanuel Lafontaine, Armelle Bertrand, Marie Pierre Santin, Aline Brun-Buisson, Christian Fine, Michael J. Roupie, Eric |
| description | Background. Although the Pneumonia Severity Index (PSI) has been extensively validated, little is known of the impact of its routine use as an aid to site-of-treatment decisions for patients with pneumonia who present to emergency departments (EDs). Methods. A prospective, observational, controlled cohort study of patients with pneumonia was conducted in 8 EDs that used the PSI (PSI-user EDs) and 8 EDs that did not use the PSI (PSI-nonuser EDs) in France. The outcomes examined included the proportion of “low-risk” patients (PSI risk classes I–III) treated as outpatients, all-cause 28-day mortality, admission of inpatients to the intensive care unit, and subsequent hospitalization of outpatients. Results. Of the 925 patients enrolled in the study, 472 (51.0%) were treated at PSI-user EDs, and 453 (49.0%) were treated at PSI-nonuser EDs; 449 (48.5%) of all patients were considered to be at low risk. In PSI-user EDs, 92 (42.8%) of 215 patients at low risk were treated as outpatients, compared with 56 (23.9%) of 234 patients at low risk in PSI-nonuser EDs. The adjusted odds ratios for outpatient treatment were higher for patients in PSI risk classes I and II who were treated in PSI-user EDs, compared with PSI-nonuser EDs (adjusted odds ratio, 7.0 [95% confidence interval, 2.0–25.0] and 4.6 [95% confidence interval, 1.3–16.2], respectively), whereas the adjusted odds ratio did not differ by PSI-user status among patients in risk class III or among patients at high risk. After adjusting for pneumonia severity, mortality was lower in patients who were treated in PSI-user EDs; other safety outcomes did not differ between patients treated in PSI-user and PSI-nonuser EDs. Conclusions. The routine use of the PSI was associated with a larger proportion of patients in PSI risk classes I and II who had pneumonia and who were treated in the outpatient environment without compromising their safety. |
| doi_str_mv | 10.1086/509331 |
| format | Article |
| fullrecord | <record><control><sourceid>jstor_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_00198753v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>4485193</jstor_id><oup_id>10.1086/509331</oup_id><sourcerecordid>4485193</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-14f59cacbdd6df861eaf81e5ccf63971e5be4f7e7c3d6ea3b356511fb8d3925d3</originalsourceid><addsrcrecordid>eNp1klFv0zAQgCMEYmPAL0DI8ICE1EBcx4nDW9Wt60TRKroJxIvlOJfVXWIX2ynrz-Qf4TbVhpB48vnuu8_y2VH0EicfcMKyjzQpCMGPomNMSR5ntMCPQ5xQFqeMsKPomXOrJMGYJfRpdIRznBKGyXH0-6vpvNKArh0gUyO_BDTX0LVGK4EWsAGr_BZd6AruUG0sOu9UpfTNHlwoD7Gp4ysLwregPToFqZwyeqeaC69CzqFfyi__kiq9bz5rwd6AltvQtBZ23_8JjdCXrvFKhg3YAZpb49YgvdrAAF2WDuwmWI0WzQCNjfbWNA1UIVwa69HCd9X2efSkFo2DF4f1JLqenF2Np_Hs8vxiPJrFMqXUxzitaSGFLKsqq2qWYRA1w0ClrDNS5CEqIa1zyCWpMhCkJDSjGNclq0gxpBU5id733qVo-NqqVtgtN0Lx6WjGd7kw7oLllGxwYN_17Nqanx04z1vlJDSN0GA6xzNGMkzYMIBv_wFXprPhuo4PcVHk4ZXZg02G6TgL9f3xOOG738D73xDA1wdbV7ZQPWCH5w_Amx4w3fr_klc9s3Le2HsqTRnFxU4R92XlPNzdl4W95VlOcsqn33_wYkJPh5_HE_6N_AFuHdST</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>219970938</pqid></control><display><type>article</type><title>Routine Use of the Pneumonia Severity Index for Guiding the Site-of-Treatment Decision of Patients with Pneumonia in the Emergency Department: A Multicenter, Prospective, Observational, Controlled Cohort Study</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>JSTOR</source><creator>Renaud, Bertrand ; Coma, Eva ; Labarere, Jose ; Hayon, Jan ; Roy, Pierre-Marie ; Boureaux, Hélène ; Moritz, Fabienne ; Cibien, Jean François ; Guérin, Thomas ; Carré, Emmanuel ; Lafontaine, Armelle ; Bertrand, Marie Pierre ; Santin, Aline ; Brun-Buisson, Christian ; Fine, Michael J. ; Roupie, Eric</creator><creatorcontrib>Renaud, Bertrand ; Coma, Eva ; Labarere, Jose ; Hayon, Jan ; Roy, Pierre-Marie ; Boureaux, Hélène ; Moritz, Fabienne ; Cibien, Jean François ; Guérin, Thomas ; Carré, Emmanuel ; Lafontaine, Armelle ; Bertrand, Marie Pierre ; Santin, Aline ; Brun-Buisson, Christian ; Fine, Michael J. ; Roupie, Eric ; Pneumocom Study Investigators ; Pneumocom Study Investigators</creatorcontrib><description>Background. Although the Pneumonia Severity Index (PSI) has been extensively validated, little is known of the impact of its routine use as an aid to site-of-treatment decisions for patients with pneumonia who present to emergency departments (EDs). Methods. A prospective, observational, controlled cohort study of patients with pneumonia was conducted in 8 EDs that used the PSI (PSI-user EDs) and 8 EDs that did not use the PSI (PSI-nonuser EDs) in France. The outcomes examined included the proportion of “low-risk” patients (PSI risk classes I–III) treated as outpatients, all-cause 28-day mortality, admission of inpatients to the intensive care unit, and subsequent hospitalization of outpatients. Results. Of the 925 patients enrolled in the study, 472 (51.0%) were treated at PSI-user EDs, and 453 (49.0%) were treated at PSI-nonuser EDs; 449 (48.5%) of all patients were considered to be at low risk. In PSI-user EDs, 92 (42.8%) of 215 patients at low risk were treated as outpatients, compared with 56 (23.9%) of 234 patients at low risk in PSI-nonuser EDs. The adjusted odds ratios for outpatient treatment were higher for patients in PSI risk classes I and II who were treated in PSI-user EDs, compared with PSI-nonuser EDs (adjusted odds ratio, 7.0 [95% confidence interval, 2.0–25.0] and 4.6 [95% confidence interval, 1.3–16.2], respectively), whereas the adjusted odds ratio did not differ by PSI-user status among patients in risk class III or among patients at high risk. After adjusting for pneumonia severity, mortality was lower in patients who were treated in PSI-user EDs; other safety outcomes did not differ between patients treated in PSI-user and PSI-nonuser EDs. Conclusions. The routine use of the PSI was associated with a larger proportion of patients in PSI risk classes I and II who had pneumonia and who were treated in the outpatient environment without compromising their safety.</description><identifier>ISSN: 1058-4838</identifier><identifier>EISSN: 1537-6591</identifier><identifier>DOI: 10.1086/509331</identifier><identifier>PMID: 17143813</identifier><language>eng</language><publisher>United States: The University of Chicago Press</publisher><subject>Aged ; Aged, 80 and over ; Articles and Commentaries ; Bacteremia ; Bacteremia - drug therapy ; Bacteremia - microbiology ; Bacteremia - mortality ; Bacteremia - physiopathology ; Cohort Studies ; Community-Acquired Infections ; Community-Acquired Infections - drug therapy ; Community-Acquired Infections - microbiology ; Community-Acquired Infections - mortality ; Community-Acquired Infections - physiopathology ; Decision Making ; Emergency departments ; Emergency medical care ; Emergency Service, Hospital ; Emergency Service, Hospital - statistics & numerical data ; Female ; Health outcomes ; Hospital admissions ; Hospitalization ; Human health and pathology ; Humans ; Infectious diseases ; Intensive care units ; Life Sciences ; Male ; Measurement ; Medical research ; Medical treatment ; Middle Aged ; Mortality ; Outpatient treatment ; Physicians ; Pneumonia ; Pneumonia, Bacterial ; Pneumonia, Bacterial - drug therapy ; Pneumonia, Bacterial - microbiology ; Pneumonia, Bacterial - mortality ; Pneumonia, Bacterial - physiopathology ; Prospective Studies ; Pulmonology and respiratory tract ; Risk Assessment ; Santé publique et épidémiologie ; Severity of Illness Index ; Severity of illness indices</subject><ispartof>Clinical infectious diseases, 2007-01, Vol.44 (1), p.41-49</ispartof><rights>Copyright 2006 The Infectious Diseases Society of America</rights><rights>2007 by the Infectious Diseases Society of America 2007</rights><rights>Copyright University of Chicago, acting through its Press Jan 1, 2007</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-14f59cacbdd6df861eaf81e5ccf63971e5be4f7e7c3d6ea3b356511fb8d3925d3</citedby><cites>FETCH-LOGICAL-c455t-14f59cacbdd6df861eaf81e5ccf63971e5be4f7e7c3d6ea3b356511fb8d3925d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/4485193$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/4485193$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,780,784,803,885,27924,27925,58017,58250</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17143813$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-00198753$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Renaud, Bertrand</creatorcontrib><creatorcontrib>Coma, Eva</creatorcontrib><creatorcontrib>Labarere, Jose</creatorcontrib><creatorcontrib>Hayon, Jan</creatorcontrib><creatorcontrib>Roy, Pierre-Marie</creatorcontrib><creatorcontrib>Boureaux, Hélène</creatorcontrib><creatorcontrib>Moritz, Fabienne</creatorcontrib><creatorcontrib>Cibien, Jean François</creatorcontrib><creatorcontrib>Guérin, Thomas</creatorcontrib><creatorcontrib>Carré, Emmanuel</creatorcontrib><creatorcontrib>Lafontaine, Armelle</creatorcontrib><creatorcontrib>Bertrand, Marie Pierre</creatorcontrib><creatorcontrib>Santin, Aline</creatorcontrib><creatorcontrib>Brun-Buisson, Christian</creatorcontrib><creatorcontrib>Fine, Michael J.</creatorcontrib><creatorcontrib>Roupie, Eric</creatorcontrib><creatorcontrib>Pneumocom Study Investigators</creatorcontrib><creatorcontrib>Pneumocom Study Investigators</creatorcontrib><title>Routine Use of the Pneumonia Severity Index for Guiding the Site-of-Treatment Decision of Patients with Pneumonia in the Emergency Department: A Multicenter, Prospective, Observational, Controlled Cohort Study</title><title>Clinical infectious diseases</title><addtitle>Clinical Infectious Diseases</addtitle><addtitle>Clinical Infectious Diseases</addtitle><description>Background. Although the Pneumonia Severity Index (PSI) has been extensively validated, little is known of the impact of its routine use as an aid to site-of-treatment decisions for patients with pneumonia who present to emergency departments (EDs). Methods. A prospective, observational, controlled cohort study of patients with pneumonia was conducted in 8 EDs that used the PSI (PSI-user EDs) and 8 EDs that did not use the PSI (PSI-nonuser EDs) in France. The outcomes examined included the proportion of “low-risk” patients (PSI risk classes I–III) treated as outpatients, all-cause 28-day mortality, admission of inpatients to the intensive care unit, and subsequent hospitalization of outpatients. Results. Of the 925 patients enrolled in the study, 472 (51.0%) were treated at PSI-user EDs, and 453 (49.0%) were treated at PSI-nonuser EDs; 449 (48.5%) of all patients were considered to be at low risk. In PSI-user EDs, 92 (42.8%) of 215 patients at low risk were treated as outpatients, compared with 56 (23.9%) of 234 patients at low risk in PSI-nonuser EDs. The adjusted odds ratios for outpatient treatment were higher for patients in PSI risk classes I and II who were treated in PSI-user EDs, compared with PSI-nonuser EDs (adjusted odds ratio, 7.0 [95% confidence interval, 2.0–25.0] and 4.6 [95% confidence interval, 1.3–16.2], respectively), whereas the adjusted odds ratio did not differ by PSI-user status among patients in risk class III or among patients at high risk. After adjusting for pneumonia severity, mortality was lower in patients who were treated in PSI-user EDs; other safety outcomes did not differ between patients treated in PSI-user and PSI-nonuser EDs. Conclusions. The routine use of the PSI was associated with a larger proportion of patients in PSI risk classes I and II who had pneumonia and who were treated in the outpatient environment without compromising their safety.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Articles and Commentaries</subject><subject>Bacteremia</subject><subject>Bacteremia - drug therapy</subject><subject>Bacteremia - microbiology</subject><subject>Bacteremia - mortality</subject><subject>Bacteremia - physiopathology</subject><subject>Cohort Studies</subject><subject>Community-Acquired Infections</subject><subject>Community-Acquired Infections - drug therapy</subject><subject>Community-Acquired Infections - microbiology</subject><subject>Community-Acquired Infections - mortality</subject><subject>Community-Acquired Infections - physiopathology</subject><subject>Decision Making</subject><subject>Emergency departments</subject><subject>Emergency medical care</subject><subject>Emergency Service, Hospital</subject><subject>Emergency Service, Hospital - statistics & numerical data</subject><subject>Female</subject><subject>Health outcomes</subject><subject>Hospital admissions</subject><subject>Hospitalization</subject><subject>Human health and pathology</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Intensive care units</subject><subject>Life Sciences</subject><subject>Male</subject><subject>Measurement</subject><subject>Medical research</subject><subject>Medical treatment</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Outpatient treatment</subject><subject>Physicians</subject><subject>Pneumonia</subject><subject>Pneumonia, Bacterial</subject><subject>Pneumonia, Bacterial - drug therapy</subject><subject>Pneumonia, Bacterial - microbiology</subject><subject>Pneumonia, Bacterial - mortality</subject><subject>Pneumonia, Bacterial - physiopathology</subject><subject>Prospective Studies</subject><subject>Pulmonology and respiratory tract</subject><subject>Risk Assessment</subject><subject>Santé publique et épidémiologie</subject><subject>Severity of Illness Index</subject><subject>Severity of illness indices</subject><issn>1058-4838</issn><issn>1537-6591</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1klFv0zAQgCMEYmPAL0DI8ICE1EBcx4nDW9Wt60TRKroJxIvlOJfVXWIX2ynrz-Qf4TbVhpB48vnuu8_y2VH0EicfcMKyjzQpCMGPomNMSR5ntMCPQ5xQFqeMsKPomXOrJMGYJfRpdIRznBKGyXH0-6vpvNKArh0gUyO_BDTX0LVGK4EWsAGr_BZd6AruUG0sOu9UpfTNHlwoD7Gp4ysLwregPToFqZwyeqeaC69CzqFfyi__kiq9bz5rwd6AltvQtBZ23_8JjdCXrvFKhg3YAZpb49YgvdrAAF2WDuwmWI0WzQCNjfbWNA1UIVwa69HCd9X2efSkFo2DF4f1JLqenF2Np_Hs8vxiPJrFMqXUxzitaSGFLKsqq2qWYRA1w0ClrDNS5CEqIa1zyCWpMhCkJDSjGNclq0gxpBU5id733qVo-NqqVtgtN0Lx6WjGd7kw7oLllGxwYN_17Nqanx04z1vlJDSN0GA6xzNGMkzYMIBv_wFXprPhuo4PcVHk4ZXZg02G6TgL9f3xOOG738D73xDA1wdbV7ZQPWCH5w_Amx4w3fr_klc9s3Le2HsqTRnFxU4R92XlPNzdl4W95VlOcsqn33_wYkJPh5_HE_6N_AFuHdST</recordid><startdate>20070101</startdate><enddate>20070101</enddate><creator>Renaud, Bertrand</creator><creator>Coma, Eva</creator><creator>Labarere, Jose</creator><creator>Hayon, Jan</creator><creator>Roy, Pierre-Marie</creator><creator>Boureaux, Hélène</creator><creator>Moritz, Fabienne</creator><creator>Cibien, Jean François</creator><creator>Guérin, Thomas</creator><creator>Carré, Emmanuel</creator><creator>Lafontaine, Armelle</creator><creator>Bertrand, Marie Pierre</creator><creator>Santin, Aline</creator><creator>Brun-Buisson, Christian</creator><creator>Fine, Michael J.</creator><creator>Roupie, Eric</creator><general>The University of Chicago Press</general><general>University of Chicago Press</general><general>Oxford University Press</general><general>Oxford University Press (OUP)</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T2</scope><scope>7T7</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope><scope>1XC</scope></search><sort><creationdate>20070101</creationdate><title>Routine Use of the Pneumonia Severity Index for Guiding the Site-of-Treatment Decision of Patients with Pneumonia in the Emergency Department: A Multicenter, Prospective, Observational, Controlled Cohort Study</title><author>Renaud, Bertrand ; Coma, Eva ; Labarere, Jose ; Hayon, Jan ; Roy, Pierre-Marie ; Boureaux, Hélène ; Moritz, Fabienne ; Cibien, Jean François ; Guérin, Thomas ; Carré, Emmanuel ; Lafontaine, Armelle ; Bertrand, Marie Pierre ; Santin, Aline ; Brun-Buisson, Christian ; Fine, Michael J. ; Roupie, Eric</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-14f59cacbdd6df861eaf81e5ccf63971e5be4f7e7c3d6ea3b356511fb8d3925d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Articles and Commentaries</topic><topic>Bacteremia</topic><topic>Bacteremia - drug therapy</topic><topic>Bacteremia - microbiology</topic><topic>Bacteremia - mortality</topic><topic>Bacteremia - physiopathology</topic><topic>Cohort Studies</topic><topic>Community-Acquired Infections</topic><topic>Community-Acquired Infections - drug therapy</topic><topic>Community-Acquired Infections - microbiology</topic><topic>Community-Acquired Infections - mortality</topic><topic>Community-Acquired Infections - physiopathology</topic><topic>Decision Making</topic><topic>Emergency departments</topic><topic>Emergency medical care</topic><topic>Emergency Service, Hospital</topic><topic>Emergency Service, Hospital - statistics & numerical data</topic><topic>Female</topic><topic>Health outcomes</topic><topic>Hospital admissions</topic><topic>Hospitalization</topic><topic>Human health and pathology</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Intensive care units</topic><topic>Life Sciences</topic><topic>Male</topic><topic>Measurement</topic><topic>Medical research</topic><topic>Medical treatment</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Outpatient treatment</topic><topic>Physicians</topic><topic>Pneumonia</topic><topic>Pneumonia, Bacterial</topic><topic>Pneumonia, Bacterial - drug therapy</topic><topic>Pneumonia, Bacterial - microbiology</topic><topic>Pneumonia, Bacterial - mortality</topic><topic>Pneumonia, Bacterial - physiopathology</topic><topic>Prospective Studies</topic><topic>Pulmonology and respiratory tract</topic><topic>Risk Assessment</topic><topic>Santé publique et épidémiologie</topic><topic>Severity of Illness Index</topic><topic>Severity of illness indices</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Renaud, Bertrand</creatorcontrib><creatorcontrib>Coma, Eva</creatorcontrib><creatorcontrib>Labarere, Jose</creatorcontrib><creatorcontrib>Hayon, Jan</creatorcontrib><creatorcontrib>Roy, Pierre-Marie</creatorcontrib><creatorcontrib>Boureaux, Hélène</creatorcontrib><creatorcontrib>Moritz, Fabienne</creatorcontrib><creatorcontrib>Cibien, Jean François</creatorcontrib><creatorcontrib>Guérin, Thomas</creatorcontrib><creatorcontrib>Carré, Emmanuel</creatorcontrib><creatorcontrib>Lafontaine, Armelle</creatorcontrib><creatorcontrib>Bertrand, Marie Pierre</creatorcontrib><creatorcontrib>Santin, Aline</creatorcontrib><creatorcontrib>Brun-Buisson, Christian</creatorcontrib><creatorcontrib>Fine, Michael J.</creatorcontrib><creatorcontrib>Roupie, Eric</creatorcontrib><creatorcontrib>Pneumocom Study Investigators</creatorcontrib><creatorcontrib>Pneumocom Study Investigators</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Clinical infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Renaud, Bertrand</au><au>Coma, Eva</au><au>Labarere, Jose</au><au>Hayon, Jan</au><au>Roy, Pierre-Marie</au><au>Boureaux, Hélène</au><au>Moritz, Fabienne</au><au>Cibien, Jean François</au><au>Guérin, Thomas</au><au>Carré, Emmanuel</au><au>Lafontaine, Armelle</au><au>Bertrand, Marie Pierre</au><au>Santin, Aline</au><au>Brun-Buisson, Christian</au><au>Fine, Michael J.</au><au>Roupie, Eric</au><aucorp>Pneumocom Study Investigators</aucorp><aucorp>Pneumocom Study Investigators</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Routine Use of the Pneumonia Severity Index for Guiding the Site-of-Treatment Decision of Patients with Pneumonia in the Emergency Department: A Multicenter, Prospective, Observational, Controlled Cohort Study</atitle><jtitle>Clinical infectious diseases</jtitle><stitle>Clinical Infectious Diseases</stitle><addtitle>Clinical Infectious Diseases</addtitle><date>2007-01-01</date><risdate>2007</risdate><volume>44</volume><issue>1</issue><spage>41</spage><epage>49</epage><pages>41-49</pages><issn>1058-4838</issn><eissn>1537-6591</eissn><abstract>Background. Although the Pneumonia Severity Index (PSI) has been extensively validated, little is known of the impact of its routine use as an aid to site-of-treatment decisions for patients with pneumonia who present to emergency departments (EDs). Methods. A prospective, observational, controlled cohort study of patients with pneumonia was conducted in 8 EDs that used the PSI (PSI-user EDs) and 8 EDs that did not use the PSI (PSI-nonuser EDs) in France. The outcomes examined included the proportion of “low-risk” patients (PSI risk classes I–III) treated as outpatients, all-cause 28-day mortality, admission of inpatients to the intensive care unit, and subsequent hospitalization of outpatients. Results. Of the 925 patients enrolled in the study, 472 (51.0%) were treated at PSI-user EDs, and 453 (49.0%) were treated at PSI-nonuser EDs; 449 (48.5%) of all patients were considered to be at low risk. In PSI-user EDs, 92 (42.8%) of 215 patients at low risk were treated as outpatients, compared with 56 (23.9%) of 234 patients at low risk in PSI-nonuser EDs. The adjusted odds ratios for outpatient treatment were higher for patients in PSI risk classes I and II who were treated in PSI-user EDs, compared with PSI-nonuser EDs (adjusted odds ratio, 7.0 [95% confidence interval, 2.0–25.0] and 4.6 [95% confidence interval, 1.3–16.2], respectively), whereas the adjusted odds ratio did not differ by PSI-user status among patients in risk class III or among patients at high risk. After adjusting for pneumonia severity, mortality was lower in patients who were treated in PSI-user EDs; other safety outcomes did not differ between patients treated in PSI-user and PSI-nonuser EDs. Conclusions. The routine use of the PSI was associated with a larger proportion of patients in PSI risk classes I and II who had pneumonia and who were treated in the outpatient environment without compromising their safety.</abstract><cop>United States</cop><pub>The University of Chicago Press</pub><pmid>17143813</pmid><doi>10.1086/509331</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1058-4838 |
| ispartof | Clinical infectious diseases, 2007-01, Vol.44 (1), p.41-49 |
| issn | 1058-4838 1537-6591 |
| language | eng |
| recordid | cdi_hal_primary_oai_HAL_hal_00198753v1 |
| source | MEDLINE; Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals; JSTOR |
| subjects | Aged Aged, 80 and over Articles and Commentaries Bacteremia Bacteremia - drug therapy Bacteremia - microbiology Bacteremia - mortality Bacteremia - physiopathology Cohort Studies Community-Acquired Infections Community-Acquired Infections - drug therapy Community-Acquired Infections - microbiology Community-Acquired Infections - mortality Community-Acquired Infections - physiopathology Decision Making Emergency departments Emergency medical care Emergency Service, Hospital Emergency Service, Hospital - statistics & numerical data Female Health outcomes Hospital admissions Hospitalization Human health and pathology Humans Infectious diseases Intensive care units Life Sciences Male Measurement Medical research Medical treatment Middle Aged Mortality Outpatient treatment Physicians Pneumonia Pneumonia, Bacterial Pneumonia, Bacterial - drug therapy Pneumonia, Bacterial - microbiology Pneumonia, Bacterial - mortality Pneumonia, Bacterial - physiopathology Prospective Studies Pulmonology and respiratory tract Risk Assessment Santé publique et épidémiologie Severity of Illness Index Severity of illness indices |
| title | Routine Use of the Pneumonia Severity Index for Guiding the Site-of-Treatment Decision of Patients with Pneumonia in the Emergency Department: A Multicenter, Prospective, Observational, Controlled Cohort Study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T15%3A34%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Routine%20Use%20of%20the%20Pneumonia%20Severity%20Index%20for%20Guiding%20the%20Site-of-Treatment%20Decision%20of%20Patients%20with%20Pneumonia%20in%20the%20Emergency%20Department:%20A%20Multicenter,%20Prospective,%20Observational,%20Controlled%20Cohort%20Study&rft.jtitle=Clinical%20infectious%20diseases&rft.au=Renaud,%20Bertrand&rft.aucorp=Pneumocom%20Study%20Investigators&rft.date=2007-01-01&rft.volume=44&rft.issue=1&rft.spage=41&rft.epage=49&rft.pages=41-49&rft.issn=1058-4838&rft.eissn=1537-6591&rft_id=info:doi/10.1086/509331&rft_dat=%3Cjstor_hal_p%3E4485193%3C/jstor_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=219970938&rft_id=info:pmid/17143813&rft_jstor_id=4485193&rft_oup_id=10.1086/509331&rfr_iscdi=true |